Human trial21 participants10 daysRandomised trial

Empagliflozin Promotes Natriuresis in Diabetic Patients with Cirrhotic Refractory Ascites: A Proof-of-Concept Study

Journal of Gastrointestinal and Liver Diseases

The paper

Shi Rongya, Yuan Gao, Yunyi Gao,

Longzhen Zhou, Wei Qin, Feng Zhao, Jianru Jia,

Baoding People's Hospital · Capital Medical University

Journal of Gastrointestinal and Liver Diseases · 26 Sep 2026

doi.org/10.15403/jgld-6897 PubMed 42803247

Dasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial
Nature Metabolism · 2 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Clinical Pharmacology and Therapeutics · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026